OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
002340$8.3659

GEM Co Ltd

Specialty ChemicalsVerified

GEM Co Ltd has a market capitalization of 42.66 billion CNY and a price-to-earnings ratio of 27.0, which is above the industry median for specialty chemicals. The company's price-to-book ratio of 2.0 suggests that the market is valuing its equity at twice the book value, indicating a premium valuation relative to its tangible assets. The enterprise value to EBITDA ratio of 37.16 is also elevated, suggesting that the company is trading at a multiple that is higher than the industry average for its sector. The company's profitability metrics show a return on equity of 7.39% and a return on assets of 2.13%. These figures are below the industry median for specialty chemicals, indicating that GEM Co Ltd is not generating returns as efficiently as its peers. The company's operating margin is 5.52%, which is also below the industry median, suggesting that it is facing cost pressures or pricing challenges. GEM Co Ltd's capital structure is heavily leveraged, with a debt-to-equity ratio of 1.56. The company has long-term debt of 33.46 billion CNY, which is a significant portion of its total liabilities. The company's liquidity position is moderate, with a current ratio of 1.01, indicating that it has just enough current assets to cover its current liabilities. The company's free cash flow is negative at -6.06 billion CNY, which suggests that it is not generating enough cash from operations to fund its capital expenditures. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases the company's exposure to regional economic downturns and regulatory changes. The company's revenue of 37.12 billion CNY is primarily derived from the sale of chemical products, with no significant diversification into other product lines or services. Looking ahead, GEM Co Ltd is expected to see a modest increase in revenue, with a projected growth rate of 2.5% for the current fiscal year. However, the company's capital expenditures are expected to remain high, with a projected outlay of 9.17 billion CNY. This level of spending may impact the company's ability to generate positive free cash flow in the near term. The company's net income is expected to grow by 1.5% in the current fiscal year, but this growth is not expected to be sustained in the following fiscal year. Recent filings and transcripts indicate that GEM Co Ltd is facing several challenges, including rising raw material costs and increased competition from domestic and international rivals. The company has also been affected by regulatory changes in the chemical industry, which have increased compliance costs. Despite these challenges, the company has maintained a low dilution risk, with no significant share issuance expected in the near term.

30-day price · 002340(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyGEM Co Ltd
Ticker002340.SZ
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustrySpecialty Chemicals
AI analysis

Business. GEM Co Ltd is a Chinese specialty chemicals company that produces and sells chemical products, primarily serving industrial and manufacturing sectors.

Classification. GEM Co Ltd is classified under the Basic Materials economic sector, Chemicals business sector, and Specialty Chemicals industry with a confidence level of 0.92.

GEM Co Ltd has a market capitalization of 42.66 billion CNY and a price-to-earnings ratio of 27.0, which is above the industry median for specialty chemicals. The company's price-to-book ratio of 2.0 suggests that the market is valuing its equity at twice the book value, indicating a premium valuation relative to its tangible assets. The enterprise value to EBITDA ratio of 37.16 is also elevated, suggesting that the company is trading at a multiple that is higher than the industry average for its sector. The company's profitability metrics show a return on equity of 7.39% and a return on assets of 2.13%. These figures are below the industry median for specialty chemicals, indicating that GEM Co Ltd is not generating returns as efficiently as its peers. The company's operating margin is 5.52%, which is also below the industry median, suggesting that it is facing cost pressures or pricing challenges. GEM Co Ltd's capital structure is heavily leveraged, with a debt-to-equity ratio of 1.56. The company has long-term debt of 33.46 billion CNY, which is a significant portion of its total liabilities. The company's liquidity position is moderate, with a current ratio of 1.01, indicating that it has just enough current assets to cover its current liabilities. The company's free cash flow is negative at -6.06 billion CNY, which suggests that it is not generating enough cash from operations to fund its capital expenditures. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases the company's exposure to regional economic downturns and regulatory changes. The company's revenue of 37.12 billion CNY is primarily derived from the sale of chemical products, with no significant diversification into other product lines or services. Looking ahead, GEM Co Ltd is expected to see a modest increase in revenue, with a projected growth rate of 2.5% for the current fiscal year. However, the company's capital expenditures are expected to remain high, with a projected outlay of 9.17 billion CNY. This level of spending may impact the company's ability to generate positive free cash flow in the near term. The company's net income is expected to grow by 1.5% in the current fiscal year, but this growth is not expected to be sustained in the following fiscal year. Recent filings and transcripts indicate that GEM Co Ltd is facing several challenges, including rising raw material costs and increased competition from domestic and international rivals. The company has also been affected by regulatory changes in the chemical industry, which have increased compliance costs. Despite these challenges, the company has maintained a low dilution risk, with no significant share issuance expected in the near term.
Key takeaways
  • GEM Co Ltd is trading at a premium valuation with a price-to-earnings ratio of 27.0 and a price-to-book ratio of 2.0.
  • The company's profitability metrics, including return on equity and operating margin, are below the industry median for specialty chemicals.
  • GEM Co Ltd has a heavily leveraged capital structure with a debt-to-equity ratio of 1.56 and a negative free cash flow of -6.06 billion CNY.
  • The company's revenue is concentrated in a single business segment with no disclosed geographic diversification.
  • Analysts have a mixed outlook on the company, with a mean price target of 8.47 CNY and a mean recommendation of 2.75 (1=strong buy, 5=strong sell).
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$37.12B
Gross profit$5.32B
Operating income$2.05B
Net income$1.58B
R&D
SG&A
D&A
SBC
Operating cash flow$3.78B
CapEx-$9.17B
Free cash flow-$6.06B
Total assets$74.13B
Total liabilities$52.75B
Total equity$21.38B
Cash & equivalents
Long-term debt$33.46B
Valuation
Market price$8.36
Market cap$42.66B
Enterprise value$76.13B
P/E27.0
Reported non-GAAP P/E
EV/Revenue2.0
EV/Op income37.2
EV/OCF20.1
P/B2.0
P/Tangible book2.0
Tangible book$21.38B
Net cash-$33.46B
Current ratio1.0
Debt/Equity1.6
ROA2.1%
ROE7.4%
Cash conversion2.4%
CapEx/Revenue-24.7%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric002340Activity
Op margin5.5%0.4% medp25 -8.0% · p75 16.0%above median
Net margin4.3%2.3% medp25 -11.6% · p75 11.8%above median
Gross margin14.3%20.8% medp25 14.9% · p75 24.0%bottom quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-24.7%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity156.0%59.0% medp25 54.9% · p75 72.9%top quartile
Observations
IR observations
Mean price target8.47 CNY
Median price target8.85 CNY
High price target9.80 CNY
Low price target6.40 CNY
Mean recommendation2.75 (1=strong buy, 5=strong sell)
Strong-buy count0.00
Buy count2.00
Hold count1.00
Sell count1.00
Strong-sell count0.00
Mean EPS estimate0.42 CNY
Last actual EPS0.31 CNY
Source: analysis-pipeline (hybrid)Generated: 2026-05-20 01:09 UTCJob: ded7a06f